A highly sensitive blood test may be able to predict whether prostate cancer is cured or is likely to come back, giving doctors an early sign of whether treatments are working, U.S. researchers said Wednesday. Read more at reuters.com
The views expressed in the articles on this website are the opinions of the respective author and do not reflect the views of the Karen E. Mumford Cancer Foundation or it's Board of Directors.